Analyst Ranking
Top 2%
#99 out of 5288 analysts
Average Return
+14.57%
Win Rate
47%239 out of 506
Risk vs Reward
Poor
Good

Douglas Tsao's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Praxis Precision Medicines IncPRAX
+885.37%$33.55$330.59
2025-03-02 -
2026-03-02
Buy
Praxis Precision Medicines IncPRAX
+737.70%$38.06$318.83
2025-04-30 -
2026-04-30
Buy
Praxis Precision Medicines IncPRAX
+601.32%$47.79$335.16
2025-08-04 -
2026-06-01
Buy
Praxis Precision Medicines IncPRAX
+522.40%$53.85$335.16
2025-07-17 -
2026-06-01
Buy
Praxis Precision Medicines IncPRAX
+428.38%$14.55$76.88
2023-11-14 -
2024-11-14
Buy

Douglas Tsao Analyst Color

Get additional color on Douglas Tsao's coverage of popular stocks

Douglas Tsao's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Biohaven LtdBHVN
14Hold$10.00-12.51%Reiterates
7 days ago
Praxis Precision Medicines IncPRAX
33Buy$1,245.00+271.46%Reiterates
7 days ago
Immunovant IncIMVT
24Buy$40.00+21.73%Maintains
12 days ago
Roivant Sciences LtdROIV
25Buy$34.00+16.88%Reiterates
12 days ago
Apellis Pharmaceuticals IncAPLS
29Hold$41.00-0.07%Downgrades
2 months ago
Viridian Therapeutics IncVRDN
17Buy$22.00+29.72%Maintains
2 months ago
Minerva Neurosciences IncNERV
16Hold$7.00+44.63%Maintains
3 months ago
Xenon Pharmaceuticals IncXENE
6Buy$74.00+38.55%Maintains
3 months ago
Theravance Biopharma IncTBPH
16Buy$15.00-5.90%Maintains
3 months ago
Argenx SeARGX
40Buy$940.00+12.43%Maintains
3 months ago
Arcutis Biotherapeutics IncARQT
5Buy$34.00+58.36%Maintains
3 months ago
Outlook Therapeutics IncOTLK
19Hold$0.50-40.69%Reiterates
3 months ago
Evolus IncEOLS
25Buy$13.00+99.39%Maintains
4 months ago
Protagonist Therapeutics IncPTGX
32Buy$117.00+23.26%Maintains
4 months ago
Pacira Biosciences IncPCRX
3Buy$38.00+65.51%Reiterates
5 months ago
Rezolute IncRZLT
19Buy$5.00+38.50%Maintains
6 months ago
Rapport Therapeutics IncRAPP
3Buy$40.00+7.79%Maintains
6 months ago
Dare Bioscience IncDARE
18Buy$12.00+447.95%Reiterates
6 months ago
Cabaletta Bio IncCABA
26Buy$16.00+335.97%Reiterates
8 months ago
Alkermes PLCALKS
17Hold$46.00+8.82%Reiterates
9 months ago
EVO
10Buy$7.00-23.16%Maintains
10 months ago
Disc Medicine IncIRON
16Buy$118.00+63.96%Reiterates
a year ago
Crinetics Pharmaceuticals IncCRNX
22Buy$81.00+134.65%Reiterates
a year ago
Sage Therapeutics IncSAGE
21Hold$12.00+38.25%Reiterates
a year ago
Coherus Oncology IncCHRS
25Buy$7.00N/AReiterates
a year ago
Scpharmaceuticals IncSCPH
14Buy$18.00N/AReiterates
a year ago
Neumora Therapeutics IncNMRA
7Buy$18.00N/AReiterates
a year ago
Trevena IncTRVN
9Hold$5.00N/ADowngrades
2 years ago
Marinus Pharmaceuticals IncMRNS
18Hold$2.00N/AReiterates
2 years ago
Revance Therapeutics IncRVNC
18Hold$6.60N/AReiterates
2 years ago
Aeon Biopharma IncAEON
8Buy$360.00N/AReiterates
2 years ago
Cerevel Therapeutics Holdings IncCERE
6Hold$45.00N/ADowngrades
2 years ago
Rvl Pharmaceuticals PLCRVLPQ
3Buy$3.00N/AMaintains
3 years ago
Climb Bio IncCLYM
2Hold$6.00N/AReiterates
3 years ago
Horizon Therapeutics Public Ltd CoHZNP
1Hold$74.00N/AInitiates Coverage On
4 years ago
Therapeuticsmd IncTXMD
5Hold$10.00N/ADowngrades
4 years ago
Biohaven Pharmaceutical Holding Co LtdBHVN1
4HoldN/AN/ADowngrades
4 years ago
Histogen IncHSTOQ
2Buy$30.00N/AMaintains
4 years ago
Amryt Pharma PLCAMYT
2Buy$18.00N/AMaintains
4 years ago
Radius Health IncRDUS1
5Hold$10.00N/AMaintains
4 years ago
Gw Pharmaceuticals PLCGWPH
3Hold$220.00N/ADowngrades
5 years ago
Amag Pharmaceuticals IncAMAG
2Hold$13.75N/ADowngrades
6 years ago
Momenta Pharmaceuticals IncMNTA
4Hold$52.50N/ADowngrades
6 years ago
Chiasma IncCHMA
2Buy$10.00N/AMaintains
6 years ago
Dermira IncDERM2
1Hold$18.75N/ADowngrades
6 years ago
Icon PLCICLR
3Hold$148.00N/AMaintains
7 years ago
Teva Pharmaceutical Industries LtdTEVA
5Hold$23.00N/AMaintains
8 years ago
Phibro Animal Health CorpPAHC
1Strong Sell$33.00N/AMaintains
8 years ago
Pfenex IncPFNX
1Strong Buy$8.00N/AMaintains
8 years ago
Endo International PLCENDPQ
1Hold$10.00N/AMaintains
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.